The exploration of mitochondrial-targeted antioxidants represented a burgeoning field of research with significant implications for cardiometabolic diseases (CMD). The studies reviewed in this scoping ...

Mitoquinone (MitoQ) is a mitochondrial reactive oxygen species scavenger that is characterized by high bioavailability. Prior studies have demonstrated its neuroprotective potential. Indeed, the ...

AUCKLAND, New Zealand & IRVINE, Calif.--(BUSINESS WIRE)--MitoQ Ltd., a New Zealand-based cell health company that developed a world-first sub-cellular targeted antioxidant which directly combats cell ...

Auckland, New Zealand--(Newsfile Corp. - September 1, 2022) - MitoQ, the New Zealand-based cell health company, has launched MitoQ Pure, a health product designed to help protect against cell stress.

MitoQ, the world’s first antioxidant formula demonstrating ability to penetrate mitochondria in order to deliver antioxidants in meaningful levels, has been selected for the USA’s National Institute ...

MitoQ is an orally active antioxidant that has the ability to target mitochondrial dysfunction. The agent is currently under development by Antipodean Pharmaceuticals Inc in phase II clinical trials ...

Chronic ethanol abuse is a systemic disorder and a risk factor for acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD). However, the mechanisms involved are ...

MitoQ Ltd. today announced a complete transformation of the brand with a fresh new design, updated visual language and sustainable packaging. AUCKLAND, New Zealand & IRVINE, Calif.--(BUSINESS WIRE)-- ...

AUCKLAND, New Zealand & IRVINE, Calif., June 20, 2023--(BUSINESS WIRE)--MitoQ Ltd., a New Zealand-based cell health company known for its breakthrough cell health molecule Mitoquinol Mesylate, which ...